vs

Side-by-side financial comparison of CME Group (CME) and MILLERKNOLL, INC. (MLKN). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $955.2M, roughly 2.0× MILLERKNOLL, INC.). MILLERKNOLL, INC. runs the higher net margin — 2.5% vs 0.1%, a 2.5% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -1.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

MillerKnoll, Incorporated, doing business as Herman Miller, is an American company that produces office furniture, equipment, and home furnishings. Its best known designs include the Aeron chair, Noguchi table, Marshmallow sofa, Mirra chair, and Eames Lounge Chair. Herman Miller is also credited with the 1968 invention of the office cubicle under then–director of research Robert Propst.

CME vs MLKN — Head-to-Head

Bigger by revenue
CME
CME
2.0× larger
CME
$1.9B
$955.2M
MLKN
Growing faster (revenue YoY)
CME
CME
+16.0% gap
CME
14.5%
-1.6%
MLKN
Higher net margin
MLKN
MLKN
2.5% more per $
MLKN
2.5%
0.1%
CME

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CME
CME
MLKN
MLKN
Revenue
$1.9B
$955.2M
Net Profit
$1.2M
$24.2M
Gross Margin
39.0%
Operating Margin
0.1%
5.1%
Net Margin
0.1%
2.5%
Revenue YoY
14.5%
-1.6%
Net Profit YoY
20.7%
-29.0%
EPS (diluted)
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
MLKN
MLKN
Q1 26
$1.9B
Q4 25
$1.6B
$955.2M
Q3 25
$1.5B
$955.7M
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
Net Profit
CME
CME
MLKN
MLKN
Q1 26
$1.2M
Q4 25
$1.2B
$24.2M
Q3 25
$908.0M
$20.2M
Q2 25
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
Gross Margin
CME
CME
MLKN
MLKN
Q1 26
Q4 25
39.0%
Q3 25
38.5%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
CME
CME
MLKN
MLKN
Q1 26
0.1%
Q4 25
61.8%
5.1%
Q3 25
63.3%
5.6%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
MLKN
MLKN
Q1 26
0.1%
Q4 25
71.7%
2.5%
Q3 25
59.1%
2.1%
Q2 25
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
EPS (diluted)
CME
CME
MLKN
MLKN
Q1 26
Q4 25
$3.24
$0.35
Q3 25
$2.49
$0.29
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
MLKN
MLKN
Cash + ST InvestmentsLiquidity on hand
$2.4B
$180.4M
Total DebtLower is stronger
$3.4B
$1.3B
Stockholders' EquityBook value
$1.3B
Total Assets
$202.0B
$3.9B
Debt / EquityLower = less leverage
1.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
MLKN
MLKN
Q1 26
$2.4B
Q4 25
$4.5B
$180.4M
Q3 25
$2.6B
$167.2M
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
MLKN
MLKN
Q1 26
$3.4B
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
MLKN
MLKN
Q1 26
Q4 25
$28.7B
$1.3B
Q3 25
$28.2B
$1.3B
Q2 25
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
Total Assets
CME
CME
MLKN
MLKN
Q1 26
$202.0B
Q4 25
$198.4B
$3.9B
Q3 25
$187.1B
$3.9B
Q2 25
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B
Debt / Equity
CME
CME
MLKN
MLKN
Q1 26
Q4 25
1.02×
Q3 25
1.02×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
MLKN
MLKN
Operating Cash FlowLast quarter
$64.6M
Free Cash FlowOCF − Capex
$34.0M
FCF MarginFCF / Revenue
3.6%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
2.67×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
MLKN
MLKN
Q1 26
Q4 25
$1.1B
$64.6M
Q3 25
$968.1M
$9.4M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$776.9M
Free Cash Flow
CME
CME
MLKN
MLKN
Q1 26
Q4 25
$1.1B
$34.0M
Q3 25
$949.7M
$-21.3M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
MLKN
MLKN
Q1 26
Q4 25
66.8%
3.6%
Q3 25
61.8%
-2.2%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
MLKN
MLKN
Q1 26
Q4 25
2.0%
3.2%
Q3 25
1.2%
3.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
MLKN
MLKN
Q1 26
Q4 25
0.96×
2.67×
Q3 25
1.07×
0.47×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

MLKN
MLKN

Workplace$309.9M32%
Global Retail Segment$275.8M29%
International Contract Segment$170.9M18%
Performance Seating$101.1M11%
Lifestyle$52.9M6%
Other Products$44.6M5%

Related Comparisons